Effect of the inhibitors phenylalanine arginyl β-naphthylamide (PAβN) and 1-(1-naphthylmethyl)-piperazine (NMP) on expression of genes in multidrug efflux systems of Escherichia coli isolates from bovine mastitis

Research in Veterinary Science

Volumn 97, Issue 2, 2014, Pages 176-181

  Ospina Barrero, M A ^a   Pietralonga, P A G ^a   Schwarz, D G G ^a   Silva Junior, A ^a   Paula, S O ^a   Moreira, M A S ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Antimicrobial; Milk; Multiresistant bacteria; Therapy

Indexed keywords

1 (1 NAPHTHYLMETHYL)PIPERAZINE; AMPICILLIN; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; PHENYLALANINE ARGINYL BETA NAPHTHYLAMIDE; UNCLASSIFIED DRUG; 1-(1-NAPHTHYLMETHYL)PIPERAZINE; BACTERIAL PROTEIN; CARRIER PROTEIN; DIPEPTIDE; PHENYLALANINE ARGININE BETA-NAPHTHYLAMIDE; PIPERAZINE DERIVATIVE;

ACRA GENE; ACRB GENE; ACRE GENE; ACRF GENE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM ISOLATION; BOVINE MASTITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG DETERMINATION; EMRA GENE; EMRB; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; MULTIDRUG EFFLUX SYSTEM; NONHUMAN; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BACTERIAL COUNT; BOVINE; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PROCEDURES; VETERINARY;

BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI;

AMPICILLIN; ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CATTLE; COLONY COUNT, MICROBIAL; DIPEPTIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; MASTITIS, BOVINE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; POLYMERASE CHAIN REACTION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84925129864     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2014.05.013     Document Type: Article

References (30)

1. Alekshun, M.N., Levy, S.B., 1997. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrobial Agents and Chemotherapy 41, 2067-2075.
2. Altalhi, A.D., Hassan, S.A., 2009. Bacterial quality of raw milk investigated by Escherichia coli and isolates analysis for specific virulence-gene markers. Food Control 20, 913-917.
3. Anonymous, 2004. Applied Biosystems-guide to performing relative quantitation of gene expression using real-time quantitative PCR. Online. http:// www3.appliedbiosystems.com/cms/groups/mcb_support/documents/ generaldocuments/cms_042380.pdf. March, 2012.
4. Bambeke, F.V., Pages, J.M., Lee, V.J., 2006. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Patents on Anti-Infective Drug Discovery 1, 157-175.
5. Bohnert, J.A., Schuster, S., Fahnrich, E., Trittler, R., Kern,W.V., 2007. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). The Journal of Antimicrobial Chemotherapy 59, 1216-1222.
6. Costa, J.C., Espeschit, I.F., Pieri, F.A., Benjamin, L.A., Moreira, M.A.S., 2012. Increased production of biofilms by Escherichia coli in the presence of enrofloxacin. Veterinary Microbiology 160, 488-490.
7. Fernandes, J.B., Zanardo, L.G., Galvao, N.N., Carvalho, I.A., Nero, L.A., Moreira, M.A.S., 2011. Escherichia coli from clinical mastitis: serotypes and virulence factors. Journal of Veterinary Diagnostic Investigation 23, 1146-1152.
8. Gerken, H., Misra, R., 2004. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli. Molecular Microbiology 54, 620-631.
9. Grkovic, S., Brown, M.H., Skurray, R.A., 2002. Regulation of bacterial drug export systems. Microbiology and Molecular Biology Reviews 66, 671- 701.
10. Hirakawa, H., Takumi-Kobayashi, A., Theisen, U., Hirata, T., Nishino, K., Yamaguchi, A., 2008. AcrS/EnvR represses expression of the acrAB multidrug efflux genes in Escherichia coli. Journal of Bacteriology 190, 6276-6279.
11. Huijps, K., Hogeveen, H., Lam, T.J., Huirne, R.B., 2009. Preferences of cost factors for mastitis management among Dutch dairy farmers using adaptive conjoint analysis. Preventive Veterinary Medicine 92, 351-359.
12. Kern,W.V., Steinke, P., Schumacher, A., Schuster, S., von Baum, H., Bohnert, J.A., 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. The Journal of Antimicrobial Chemotherapy 57, 339-343.
13. Koronakis, V., Eswaran, J., Hughes, C., 2004. Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annual Review of Biochemistry 73, 467-489.
14. Li, X.Z., Nikaido, H., 2004. Efflux-mediated drug resistance in bacteria. Drugs 64, 159-204.
15. Lomovskaya, O., Bostian, K.A., 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic-a vision for applied use. Biochemical Pharmacology 71, 910-918.
16. Lomovskaya, O., Warren, M.S., Lee, A., Galazzo, J., Fronko, R., Lee, M., et al., 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrobial Agents and Chemotherapy 45, 105-116.
17. Melchior, M.B., Fink-Gremmels, J., Gaastra, W., 2007. Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilms. Veterinary Microbiology 125, 141- 149.
18. Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., Yamaguchi, A., 2006. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443, 173-179.
19. Nikaido, H., 2009. Multidrug resistance in bacteria. Annual Review of Biochemistry 78, 119-146.
20. Nikaido, H., Takatsuka, Y., 2009. Mechanisms of RND multidrug efflux pumps. Biochimica et Biophysica Acta 1794, 769-781.
21. Piddock, L.J., 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clinical Microbiology Reviews 19, 382-402.
22. Poole, K., 2007. Efflux pumps as antimicrobial resistance mechanisms. Annals of Medicine 39, 162-176.
23. Pos, K.M., 2009. Drug transport mechanism of the AcrB efflux pump. Biochimica et Biophysica Acta 1794, 782-793.
24. Ricci, V., Piddock, L.J., 2009. Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium. The Journal of Antimicrobial Chemotherapy 64, 654-657.
25. Rosenberg, E.Y., Bertenthal, D., Nilles, M.L., Bertrand, K.P., Nikaido, H., 2003. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Molecular Microbiology 48, 1609-1619.
26. Sánchez-Céspedes, J., Vila, J., 2007. Partial characterisation of the acrAB locus in two Citrobacter freundii clinical isolates. International Journal of Antimicrobial Agents 30, 259-263.
27. Takatsuka, Y., Chen, C., Nikaido, H., 2010. Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proceedings of the National Academy of Sciences U.S.A. 107, 6559-6565.
28. Thorarensen, A., Presley-Bodnar, A.L., Marotti, K.R., Boyle, T.P., Heckaman, C.L., Bohanon, M.J., et al., 2001. 3-Arylpiperidines as potentiators of existing antibacterial agents. Bioorganic & Medicinal Chemistry Letters 11, 1903-1906.
29. Viveiros, M., Dupont, M., Rodrigues, L., Couto, I., Davin-Regli, A., Martins, M., et al., 2007. Antibiotic stress, genetic response and altered permeability of Escherichia coli. PLoS ONE 2, e365.
30. Wenz, J.R., Barrington, G.M., Garry, F.B., Ellis, R.P., Magnuson, R.J., 2006. Escherichia coli isolates' serotypes, genotypes, and virulence genes and clinical coliform mastitis severity. Journal of Dairy Science 89, 3408-3412.